MAGNAM Trial, Magnesium Versus Amiodarone in AF in Critical Care
Condition:   Atrial Fibrillation New Onset Interventions:   Drug: Magnesium sulfate and then Digoxin;   Drug: Amiodarone Sponsors:   Sunnybrook Health Sciences Centre;   Sunnybrook Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials

Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery
Conditions:   New Onset Atrial Fibrillation;   Complications; Cardiac, Postoperative Interventions:   Drug: Nifekalant;   Drug: Amiodarone Sponsor:   Beijing Anzhen Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials